Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Published Online: 2018-06-?
Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC
Authors: Alain Ravaud•Alpa Thobhani•Bernard Escudier•Brian I. Rini•Christina Schiff•Cristina Suárez•Daniel S. Chen•David F. McDermott•Dorothee Nickles•Elisabeth Piault-Louis•Gregg D. Fine•James A. Reeves•Jiaheng Qiu•John Hainsworth•Lawrence Fong•Mahrukh A. Huseni•Mario Sznol•Martin E. Gore•Michael B. Atkins•Priti S. Hegde•Riccardo Danielli•Richard W. Joseph•Robert J. Motzer•Sergio Bracarda•Suchit Jhunjhunwala•Sumanta K. Pal•Thomas Hutson•Thomas Powles•Toni K. Choueiri•Viktor Gruenwald•W. Kimryn Rathmell•Walter M. Stadler
